FRANKFURT (Reuters) -German COVID-19 vaccine maker BioNTech on Monday said that its 2025 revenues would likely fall to ...

Already competing to bring the first vaccine against respiratory syncytial virus (RSV) to market, Pfizer and GSK are also fighting a patent infringement battle in the courts. Earlier this month ...

Just days after anti-vaccine advocate Robert F. Kennedy Jr. became the country's top health official, the Centers for Disease Control and Prevention has already pulled back some of its efforts to ...

He also added RSV vaccine may be given to mother late in pregnancy or a long-acting antibody can be given to the infant shortly after birth to protect the infant from severe RSV disease.